Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Stem Cells Market, By Product
7.1. Stem Cells Market, by Product Type, 2020-2030
7.1.1. Adult Stem Cells (ASCs)
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Human Embryonic Stem Cells (HESCs)
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Induced Pluripotent Stem Cells (iPSCs)
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Very Small Embryonic Like Stem Cells
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Stem Cells Market, By Application
8.1. Stem Cells Market, By Application, 2020-2030
8.1.1. Regenerative Medicine
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Drug Discovery and Development
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Stem Cells Market, By Technology Type
9.1. Stem Cells Market, By Technology Type, 2020-2030
9.1.1. Cell Acquisition
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Cell Production
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Cryopreservation
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Expansion and Sub-Culture
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Stem Cells Market, By Therapy Type
10.1. Stem Cells Market, By Therapy Type, 2020-2030
10.1.1. Autologous
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Allogenic
10.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Stem Cells Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.2. Market Revenue and Forecast, By Application (2016-2030)
11.1.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.1.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.2.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Application (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.3.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Application (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.4.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Application (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.5.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.5.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Application (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Application (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Technology Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, By Therapy Type (2016-2030)
Chapter 12. Company Profiles
12.1. CELGENE CORPORATION
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. ReNeuron Group plc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Virgin Health Bank
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Biovault family
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Precious Cells International Ltd
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Mesoblast Ltd
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Caladrius
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Seneca Biopharmaceuticals, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Opexa Therapeutics, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. STEMCELL Technologies Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Pluristem Therapeutics Inc
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.12. ThermoGenesis Holdings, Inc
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.13. Astellas Pharma Inc.
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.14. Cellular Engineering Technologies
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.15. BioTime, Inc.
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Audiology Devices Market (By Product: Hearing Aids, Cochlear Implants; By Technology: Digital, Analog; By Sales Channel: Retail, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.
Read more...
Micro-pumps Market (By Product: Mechanical, Non-mechanical; By Application: Drug Delivery, Medical Devices; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.
Read more...
U.S. Behavioral Health Care Software And Services Market (By Component: Software, Support Services; By Delivery Model; By Function; By End Use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.
Read more...
Medical Imaging Market (By Product: X-ray, CT, MRI, Ultrasound; By End-use: Hospitals, Diagnostic Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.
Read more...
Medical Imaging Phantoms Market (By Device Type: X-ray, Ultrasound, CT, MRI; By End Use; By Material: Simulating Organs, False Organs) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.
Read more...